Skip to content
TrustList
RocaX logo
Venture capital firm

RocaX

Romanian investment platform for start-ups between business angels and later-stage venture funds

RocaX cover

About RocaX

RocaX, also written ROCA X, is a Romanian investment platform for technology start-ups at the earliest stage. It aims to bridge the gap between the business angels who nurture ideas and the venture funds that back growth. The firm is fully privately owned, so it can invest flexibly across its target regions.

Products and services

  • Early-stage investment: funding for young entrepreneurs whose ideas are at the prototype or minimum viable product stage.
  • Model validation: help for selected start-ups to test and refine how their business works.
  • Growth acceleration: support that moves promising companies towards scale.
  • Network access: the contacts of the Impetum Group and well-known Romanian entrepreneurs.

Who it works with

The target is disruptive technology start-ups with a social impact. Partner organisations named on the site include Google for Startups, the European Startup Association, AWS Activate and TechAngels. Recent news mentions a Romanian cybersecurity start-up.

Key facts

  • Based in: Romania
  • Parent: Impetum Group, alongside CITR and ROCA

Profile written by TrustList from the business's own published information, Oct 2026.

Categories & features

  • Buy
  • Cybersecurity
  • Business
  • AWS
  • Us,
  • Partners

Ask TrustList to introduce you to RocaX

TrustList reads every request before passing it on, and sends it only where the funder's stage and focus look like a fit. We do not charge for introductions, and we cannot promise a reply.

Protected by reCAPTCHA — Google Privacy Policy and Terms apply.

Reviews

Write the first review of RocaX

Used it? Your experience helps other buyers decide.

Write a review

Questions & answers

No questions yet. Be the first to ask about RocaX.

RocaX alternatives

Similar listings buyers compare against this one.

Venture capital firm investing in early to growth-stage fintech companies through a network of banks

Life sciences venture firm investing in early-stage treatments and diagnostics for rare diseases

Investment manager backing early-stage cannabis and other emerging-industry companies for institutional investors